1. Home
  2. ERC vs EOLS Comparison

ERC vs EOLS Comparison

Compare ERC & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allspring Multi-Sector Income Fund

ERC

Allspring Multi-Sector Income Fund

HOLD

Current Price

$8.85

Market Cap

259.5M

Sector

Finance

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$4.56

Market Cap

304.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERC
EOLS
Founded
2003
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
259.5M
304.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ERC
EOLS
Price
$8.85
$4.56
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.50
AVG Volume (30 Days)
73.4K
1.4M
Earning Date
01-01-0001
03-03-2026
Dividend Yield
8.37%
N/A
EPS Growth
N/A
1.23
EPS
0.72
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
N/A
$13.37
Revenue Next Year
N/A
$17.56
P/E Ratio
$12.25
N/A
Revenue Growth
N/A
11.61
52 Week Low
$8.65
$4.09
52 Week High
$9.78
$13.10

Technical Indicators

Market Signals
Indicator
ERC
EOLS
Relative Strength Index (RSI) 29.57 42.49
Support Level N/A $4.10
Resistance Level $9.47 $4.99
Average True Range (ATR) 0.10 0.37
MACD -0.02 -0.04
Stochastic Oscillator 9.47 2.02

Price Performance

Historical Comparison
ERC
EOLS

About ERC Allspring Multi-Sector Income Fund

Allspring Multi-Sector Income Fund is a closed-end investment management company. The company's core business is to secure a high level of income for its investors consistent with limiting its overall exposure to domestic interest rate risk. It invests in U.S. dollar-denominated below investment-grade bonds, debentures, and other income obligations, including loans and preferred stocks, developed and emerging market debt securities, including obligations of foreign governments or governmental entities, foreign corporations, or supranational agencies denominated in various currencies, asset backed securities and investment grade corporate bonds.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: